Disposition and Bioavailability of Various Formulations of Tetrahydrocannabinol in the Rhesus Monkey
- 1 February 1985
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 74 (2), 171-174
- https://doi.org/10.1002/jps.2600740213
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and womenClinical Pharmacology & Therapeutics, 1983
- Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smokingClinical Pharmacology & Therapeutics, 1980
- Δ9-Tetrahydrocannabinol for Refractory Vomiting Induced by Cancer ChemotherapyJAMA, 1980
- Antiemetics in Patients Receiving Chemotherapy for CancerThe New England Journal of Medicine, 1980
- Delta-9-Tetrahydrocannabinol as an Antiemetic for Patients Receiving Cancer ChemotherapyAnnals of Internal Medicine, 1979
- Delta-9-Tetrahydrocannabinol as an Antiemetic in Cancer Patients Receiving High-Dose MethotrexateAnnals of Internal Medicine, 1979
- Radioimmunoassay of Cannabinoid CompoundsPublished by American Chemical Society (ACS) ,1979
- Pharmacokinetics of Δ9-Tetrahydrocannabinol in DogsJournal of Pharmaceutical Sciences, 1977
- Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer ChemotherapyThe New England Journal of Medicine, 1975
- Statistical estimations in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1974